DNA is the most important molecular aspect of our bodies. It constitutes the expression and action of so many different processes within our cells and makes each person function in the way a human should. Every day, the strands of DNA that make up the various cells and components in our body experience billions of different types of damage and lesions in their makeup. Some of this damage is a result of the regular metabolic processes inside individual cells to produce energy and synthesize more material.
Another portion of the damage comes from a wide array of environmental and external factors. Nonetheless, the damage that DNA receives daily requires correction for cells to continue functioning and working for our benefit. Without continuous active repair, the integrity of our genome would become compromised. DNA repair involves many different types of actions that a cell can take to make these fixes occur and displays specificity for certain types of damage and strain.
DNA damage plays an integral part in the development of cancer and other diseases. The mediators of DNA damage are both exogenous and endogenous. Endogenous damage occurs within the cell as a result of normal cellular processes such as errors caused during DNA replication such as incorrect nucleotide insertion or mismatches, DNA instability resulting from depurination (cleavage of bonds between the deoxyribose sugar and the purine base) or due to free radicals formed during oxidation-reduction reactions such as deamination of DNA and proteins.
Most of these errors are corrected by DNA polymerase during replication with its inherent proofreading mechanism via its 3'-exonuclease activity. This mechanism allows for the polymerase to read the most recently placed base before adding the next one. If the base does not pair correctly with the base on the template strand, then the exonuclease mechanism of DNA pol III cuts the phosphodiester bond holding that section of the strand and releases the nucleotide. This process is not perfect, however, and incorrect bases are commonly left in the newly synthesized DNA strand. Mismatch repair proteins correct this by locating incorrectly matched nucleotides and excising them before placing the correct nucleotide in its place.
Exogenous damage, also called induced damage, is the result of external factors acting on the cell. The common causes of exogenous damage include Radiation such as UV light exposure (UVA and UVB) and ionizing radiations, thermal disruptions, toxins, and drugs that cause base-pair mismatches, intercalation causing inhibition of replication. UV damage causes the cross-linking of adjacent cytosine and thymine bases, forming harmful dimers.
Ionizing radiations such as X-rays can dissociate water molecules in the cell, producing hydroxyl radicals that can react with DNA, altering its structure and cause DNA strands to break. Certain toxins and drugs cause chemical associations resulting in single or double-strand breakage in the DNA helix. Thermal disruption via DNA being exposed to high temperatures causes higher rates of depurination to occur, as well as single-strand breaks. Radiation exposure also causes strand breaks. These types of induced damage are very severe and can cause irreparable damage and harm to the cell. Similarly, environmental toxins such as cigarette smoke contain carcinogens like benzo-pyrene. These chemicals can be oxidized by cellular enzymes and cause DNA damage by forming DNA adducts.
Damage inflicted on the DNA during or after replication and transcription are not to be confused with mutations. DNA damage results in single and double-strand breakages and is repairable by the different actions of enzymes in the cell. This is because the enzymes have a template for repair present in either the complementary strand of a damaged DNA molecule or a homologous chromosome that can be copied and used to implement the correct base pairs and base orders in the double helix.
Mutation, on the other hand, is a permanent alteration to the base pair sequence of the host's DNA. It is irreparable to enzymes as mutation leaves no template for the correct base pair sequence to be integrated into the strand. Mutation can also cause changes in how certain genes are expressed, in contrast to damage, which causes either a halt in gene function or is deleterious to the cell. Damage may lead to mutation, but while mutation may lead to harmful byproducts, it does not cause direct damage to the mutated gene or DNA molecule.
There are many types of repair that are specific to certain types of damage inflicted on a DNA molecule and focus on ssDNA or dsDNA.
Single strand DNA (ssDNA) repair mechanisms include mismatch repair, base excision repair, and nucleotide excision repair.
Double strand DNA (dsDNA) damage is much harder to repair because the damaged helix has no template from which to copy and replace the afflicted bases and nucleotides. Two major pathways can alleviate issues involving double-stranded breaks: homologous recombination and non-homologous end-joining.
DNA repair is crucial to correcting the mistakes our replicative machinery makes when forming new materials within our bodies. Damage to DNA molecules, if left unrepaired, can often lead to carcinogenesis, which is the development of cancer cells in the affected area that can easily spread and replicate through mitosis. Conversely, cancer developments can be understood and analyzed through the mechanisms in which DNA damage occurs, and repair processes are affected as a result of the carcinogens in the body. This process has received extensive study relative to exogenous damage such as ionizing radiation that can lead to leukemia and melanoma due to various exposures, ranging from simple ultraviolet to X-ray.
Novel methods are under development to target DNA repair pathways that have suffered mutagenetic effects and use them to fight the tumor to induce malignant cell death. DNA repair can be recruited to the carcinogens benefit, so the goal of this area of research is to turn the repair pathways back on the tumor and induce its degradation.
|||Hakem R, DNA-damage repair; the good, the bad, and the ugly. The EMBO journal. 2008 Feb 20; [PubMed PMID: 18285820]|
|||Grady WM,Ulrich CM, DNA alkylation and DNA methylation: cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas? Gut. 2007 Mar; [PubMed PMID: 17339242]|
|||Best BP, Nuclear DNA damage as a direct cause of aging. Rejuvenation research. 2009 Jun [PubMed PMID: 19594328]|
|||Chatterjee N,Walker GC, Mechanisms of DNA damage, repair, and mutagenesis. Environmental and molecular mutagenesis. 2017 Jun [PubMed PMID: 28485537]|
|||Li Z,Pearlman AH,Hsieh P, DNA mismatch repair and the DNA damage response. DNA repair. 2016 Feb [PubMed PMID: 26704428]|
|||Black JO, Xeroderma Pigmentosum. Head and neck pathology. 2016 Jun [PubMed PMID: 26975629]|
|||Wallace SS, Base excision repair: a critical player in many games. DNA repair. 2014 Jul [PubMed PMID: 24780558]|
|||Reardon JT,Sancar A, Purification and characterization of Escherichia coli and human nucleotide excision repair enzyme systems. Methods in enzymology. 2006 [PubMed PMID: 16793370]|
|||Truong LN,Li Y,Shi LZ,Hwang PY,He J,Wang H,Razavian N,Berns MW,Wu X, Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 2013 May 7 [PubMed PMID: 23610439]|
|||[PubMed PMID: 15546503]|
|||[PubMed PMID: 31921645]|
|||Waissi W,Paix A,Nicol A,Noël G,Burckel H, Targeting DNA repair in combination with radiotherapy in pancreatic cancer: A systematic review of preclinical studies. Critical reviews in oncology/hematology. 2020 Jul 11; [PubMed PMID: 32707435]|
|||Shaib WL,Zakka KM,Jiang R,Yan M,Alese OB,Akce M,Wu C,Behera M,El-Rayes BF, Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer. Cancer. 2020 Jul 22; [PubMed PMID: 32697360]|
|||Juszczak M,Kluska M,Wysokiński D,Woźniak K, DNA damage and antioxidant properties of CORM-2 in normal and cancer cells. Scientific reports. 2020 Jul 22; [PubMed PMID: 32699258]|